Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06489249
EARLY_PHASE1

Role of Inflammation in Vascular Phenotype Associated With E-cigarette Use

Sponsor: University of Iowa

View on ClinicalTrials.gov

Summary

The use of electronic nicotine delivery systems, or e-cigarettes - colloquially referred to as "vaping" - in the United States has increased exponentially since their introduction to the US market in 2007. Prevalence of ever and current e-cigarette use is highest among teenagers and young adults with 16-28% of this population having reported vaping. While the majority of e-cigarette users are current tobacco smokers, 32.5% of current e-cigarette users are never- or former-smokers, representing a growing population of young adults who exclusively vape. While e-cigarettes have been marketed as a safer alternative to tobacco cigarettes, clinical studies examining these claims are limited. Cardiovascular disease (CVD) is the primary cause of premature death among tobacco cigarette smokers and reductions in vascular endothelial function, a significant predictor of future CVD, are detectible in otherwise healthy young adults who smoke. Despite the explosion in e-cigarette use among young adults, the health effects - especially the effects on mechanisms of vascular function - of these devices remain relatively unexplored. The purpose of this study is to directly asses the mechanistic role of inflammation in this dysfunction.

Key Details

Gender

All

Age Range

18 Years - 24 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2024-08-15

Completion Date

2026-10

Last Updated

2025-12-15

Healthy Volunteers

Yes

Interventions

DRUG

Placebo

Oral placebo tablet

DRUG

Salsalate 750 MG Oral Tablet [DISALCID]

Oral salsalate tablet

Locations (2)

Iowa Bioscience Innovation Facility

Iowa City, Iowa, United States

University of Iowa

Iowa City, Iowa, United States